Dearborn Partners LLC Sells 6,424 Shares of Colgate-Palmolive (CL)

Dearborn Partners LLC trimmed its holdings in Colgate-Palmolive (NYSE:CL) by 40.8% in the first quarter, Holdings Channel reports. The fund owned 9,322 shares of the company’s stock after selling 6,424 shares during the period. Dearborn Partners LLC’s holdings in Colgate-Palmolive were worth $639,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. BB&T Corp lifted its holdings in shares of Colgate-Palmolive by 1.2% in the 1st quarter. BB&T Corp now owns 274,086 shares of the company’s stock worth $18,786,000 after acquiring an additional 3,129 shares during the last quarter. Ffcm LLC lifted its holdings in shares of Colgate-Palmolive by 5.6% in the 4th quarter. Ffcm LLC now owns 63,206 shares of the company’s stock worth $3,762,000 after acquiring an additional 3,325 shares during the last quarter. Nachman Norwood & Parrott Inc raised its holdings in Colgate-Palmolive by 1.9% during the 1st quarter. Nachman Norwood & Parrott Inc now owns 11,101 shares of the company’s stock valued at $761,000 after buying an additional 209 shares during the last quarter. Strs Ohio raised its holdings in Colgate-Palmolive by 1.9% during the 1st quarter. Strs Ohio now owns 415,958 shares of the company’s stock valued at $28,509,000 after buying an additional 7,713 shares during the last quarter. Finally, River & Mercantile Asset Management LLP bought a new stake in Colgate-Palmolive during the 4th quarter valued at $7,765,000. Hedge funds and other institutional investors own 75.99% of the company’s stock.

CL has been the subject of a number of recent analyst reports. Goldman Sachs Group upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a report on Tuesday, January 8th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Thursday, January 10th. Evercore ISI initiated coverage on shares of Colgate-Palmolive in a report on Thursday, January 10th. They set an “outperform” rating and a $70.00 price target for the company. Wells Fargo & Co reiterated a “hold” rating and set a $57.00 price target on shares of Colgate-Palmolive in a report on Friday, January 25th. Finally, Morgan Stanley set a $62.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Tuesday, January 29th. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and an average price target of $69.81.

Shares of Colgate-Palmolive stock opened at $71.69 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 0.74 and a debt-to-equity ratio of 32.25. The firm has a market cap of $61.77 billion, a price-to-earnings ratio of 24.14, a P/E/G ratio of 4.72 and a beta of 0.81. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $72.85.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.74 EPS. On average, analysts forecast that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.43 dividend. The ex-dividend date of this dividend is Wednesday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.40%. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.

In other news, SVP John J. Huston sold 36,878 shares of the company’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $71.85, for a total value of $2,649,684.30. Following the sale, the senior vice president now directly owns 110,611 shares of the company’s stock, valued at approximately $7,947,400.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Noel R. Wallace sold 84,351 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $71.89, for a total transaction of $6,063,993.39. Following the completion of the sale, the chief executive officer now directly owns 279,023 shares in the company, valued at $20,058,963.47. The disclosure for this sale can be found here. Insiders sold a total of 246,149 shares of company stock worth $17,203,908 over the last ninety days. Insiders own 1.14% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Dearborn Partners LLC Sells 6,424 Shares of Colgate-Palmolive (CL)” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thelincolnianonline.com/2019/05/07/dearborn-partners-llc-sells-6424-shares-of-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: Special Dividends

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.